Skip to main content
. 2024 Feb 20;15:1551. doi: 10.1038/s41467-024-45000-z

Fig. 7. Clinical impact of 1q&13 classification.

Fig. 7

Effect on PFS and OS of 1q&13 classification: a BO dataset (n = 512 patients) 5-year PFS: 22% vs. 37% vs. 47%, log-rank test p = 0.000042; (b) OS: 50% vs. 74% vs. 78%, log-rank test p = 0.0003, for 1q&13 + , 1q/13, 1q&13-, respectively. c CoMMpass dataset (n = 752 patients) 3-year PFS: 37% vs. 43% vs. 55%, log-rank test p = 0.0003; (d) OS: 67% vs. 76% vs. 81%, log-rank test p = 0.002, for 1q&13 + , 1q/13, 1q&13-, respectively.